These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 13975881)
21. THE STORY OF POLIOMYELITIS VACCINES. FERGUSON JK Can J Public Health; 1964 May; 55():183-90. PubMed ID: 14161448 [No Abstract] [Full Text] [Related]
22. [ON THE EFFECT OF DEXTRAN SULFATE ON SABIN ORAL POLIOMYELITIS VACCINAL STRAINS]. VOSS H Z Naturforsch B; 1964 Mar; 19():226-9. PubMed ID: 14175997 [No Abstract] [Full Text] [Related]
23. [STUDIES ON THE TOLERANCE AND EFFICACY OF LIVE POLIOMYELITIS VIRUS VACCINE TYPE I]. HENNESSEN W; ALTEVOGT R; MAULER R; LANGE A; BOEHM R Dtsch Med Wochenschr; 1963 Dec; 88():2387-90. PubMed ID: 14163000 [No Abstract] [Full Text] [Related]
24. [Killed (Salk type) or living (Sabin type) poliomyelitis vaccine?]. VERLINDE JD Ned Tijdschr Geneeskd; 1962 Dec; 106():2599-604. PubMed ID: 13996794 [No Abstract] [Full Text] [Related]
25. POLIOMYELITIS--VIRGINIA 1963. SHANHOLTZ MI Va Med Mon (1918); 1964 Feb; 91():72-4. PubMed ID: 14119137 [No Abstract] [Full Text] [Related]
26. Poliomyelitis in Kenya--the 1960 epidemic and oral vaccine campaign. FENDALL NR J Trop Med Hyg; 1962 Oct; 65():245-55. PubMed ID: 13962908 [No Abstract] [Full Text] [Related]
27. [POLIOMYELITIS IN THE CHILD. REFERENCES TO VIROLOGICAL FINDINGS]. GONZALEZ M; SCROGGIE S; DIAZ R Rev Chil Pediatr; 1964 Jan; 35():24-8. PubMed ID: 14163294 [No Abstract] [Full Text] [Related]
28. [THE VALUE OF GENETIC MARKERS OF THE POLIOVIRUS FOR THE EVALUATION OF SUPPOSED INCIDENTS FOLLOWING ORAL VACCINATION]. POETSCH F Zentralbl Bakteriol Orig; 1963 Dec; 191():112-6. PubMed ID: 14119890 [No Abstract] [Full Text] [Related]
30. ANTIGENIC VARIATIONS AMONG TYPE III POLIOMYELITIS VIRUSES. DEIBEL R; MACDONALD D N Y State J Med; 1964 Aug; 64():2058-65. PubMed ID: 14180893 [No Abstract] [Full Text] [Related]
32. [ANTIBODY FORMATION AFTER 3 DOSES OF QUADRUPLE VACCINE INJECTION FOLLOWED BY TRIVALENT ORAL POLIOMYELITIS VACCINE]. HENIGST W; MUELLER F Dtsch Med Wochenschr; 1965 Aug; 90():1502-6. PubMed ID: 14344415 [No Abstract] [Full Text] [Related]
33. [EXPERIENCE OF THE "DR. I. CANTACUZINO" INSTITUTE CONCERNING THE PREPARATION AND CONTROL OF POLIOMYELITIS VACCINES]. MESROBEANU I; ARION R; WISNER B Arch Roum Pathol Exp Microbiol; 1963 Sep; 23():713-8. PubMed ID: 14165850 [No Abstract] [Full Text] [Related]
35. [SHOULD ATTENUATED POLIOMYELITIS VIRUS VACCINE BE ADMINISTERED TO SUBJECTS PREVIOUSLY VACCINATED BY KILLED VIRUS?]. GILLET P; THIRY L Acta Paediatr Belg; 1964; 18():145-61. PubMed ID: 14166431 [No Abstract] [Full Text] [Related]
36. Present approach to immunization for poliomyelitis. GITHENS JH J Ky Med Assoc; 1963 Jun; 61():494-7. PubMed ID: 13948238 [No Abstract] [Full Text] [Related]
37. [Anti-poliomyelitis vaccination with attenuated live virus]. BONNET F; LAMBRECHTS A Rev Med Liege; 1963 Mar; 18():140-8. PubMed ID: 13968824 [No Abstract] [Full Text] [Related]
38. [CURRENT STATUS OF ANTI-POLIOMYELITIS VACCINATION]. RAGAZZINI F Arcisp S Anna Ferrara; 1964; 17():467-78. PubMed ID: 14197776 [No Abstract] [Full Text] [Related]
39. Conclusions and recommendations of the Advisory Committee on Poliomyelitis Eradication, Geneva, 11-12 October 2006, Part II. Wkly Epidemiol Rec; 2006 Dec; 81(49/50):465-8. PubMed ID: 17153242 [No Abstract] [Full Text] [Related]
40. [VACCINATION METHODS AND IMMUNIZATION AGAINST POLIOMYELITIS]. LEPINE P Arch Ital Sci Med Trop Parassitol; 1964 Aug; 45():391-414. PubMed ID: 14212901 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]